Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Travel Awards - Institute Community Support

Queen's University (Kingston, Ontario)

$1,000.00

Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants and warfarin in routine practice: interim results from a multi-centre cohort

EF 2016-17

Résumé
Atrial fibrillation is a heart condition that increases the chance of stroke in the elderly, and this can be prevented through anticoagulation, or blood-thinning. Too much blood-thinning, however, can lead to bleeding and death. Recent approval of 4 new blood thinners have increased the options we have to treat people who have atrial fibrillation. Until recently, however, there is no approved antidote to reverse the effect of these drugs in hospital once bleeding begins. Therefore, we wanted to find out the current types of treatment for elderly patients who present to five major hospitals in Ontario with bleeds from new blood-thinners and warfarin, and whether outcomes after treatment are different between these two groups of patients.
Programme
Travel Awards - Institute Community Support
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
352247
Name
Xu Yan
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Institute of Circulatory and Respiratory Health
Projecttitle
Reversal strategies and outcomes of major bleeding associated with direct oral anticoagulants and warfarin in routine practice: interim results from a multi-centre cohort
Programtype2
Undefined
Orgnameinp2
Queen's University (Kingston, Ontario)
Cihramount2
$1,000
Cihrequipment2
$0
Programname2
Travel Awards - Institute Community Support
Keyworddelim
Ics Travel Awards
Abstract
Atrial fibrillation is a heart condition that increases the chance of stroke in the elderly, and this can be prevented through anticoagulation, or blood-thinning. Too much blood-thinning, however, can lead to bleeding and death. Recent approval of 4 new blood thinners have increased the options we have to treat people who have atrial fibrillation. Until recently, however, there is no approved antidote to reverse the effect of these drugs in hospital once bleeding begins. Therefore, we wanted to find out the current types of treatment for elderly patients who present to five major hospitals in Ontario with bleeds from new blood-thinners and warfarin, and whether outcomes after treatment are different between these two groups of patients.
Competitiondate
201607
Approvedterm2
1 yr 0 mth
Pinamesdelim
Xu, Yan
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $1,000~ $0~